AzTrials
AzTrials

PancreatectomyNCT06424431

Methods of Pancreatic Stump Closure for Distal Pancreatectomy

A study testing stapler combined with electrocautery and simple closure with a closure device in people with Pancreatectomy, run by Changhai Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to conduct a retrospective analysis of patients who underwent distal pancreatectomy in our hospital, aiming to evaluate the safety and feasibility of two methods for closure of the pancreatic remnant: simple closure with a closure device and closure combined with electrocoagulation. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Pancreatectomy
What is being tested?
stapler combined with electrocautery and simple closure with a closure device
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
487 participants
Where
1 siteChina
Study dates
1 Jan 2019to 1 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who underwent distal pancreatectomy performed by Director Jin Gang's team at Changhai Hospital affiliated with Naval Medical University between January 2019 and January 2023.
  • Patients who underwent closure of the pancreatic remnant using either simple closure or closure combined with electrocoagulation during surgery.

Who cannot join

  • Patients undergoing surgeries by other primary clinical teams during the same period.
  • Patients undergoing closure of the pancreatic remnant using methods other than those mentioned.
  • Patients who violate the requirements of the study protocol.
  • Patients with incomplete data collection in the hospital's diagnostic and treatment system.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Changhai Hospital

    Shanghai, Shanghai Municipality

Other trials in China

About this study

Official title: Stapler Versus Stapler Combined With Electrocautery for Pancreatic Transection and Stump Closure for Distal Pancreatectomy

The aim of this study is to conduct a retrospective analysis of patients who underwent distal pancreatectomy in our hospital, aiming to evaluate the safety and feasibility of two methods for closure of the pancreatic remnant: simple closure with a closure device and closure combined with electrocoagulation.

Read the detailed description

The aim of this study is to conduct a retrospective analysis of patients who underwent distal pancreatectomy in our hospital, aiming to evaluate the safety and feasibility of two methods for closure of the pancreatic remnant: simple closure with a closure device and closure combined with electrocoagulation. This study aims to determine which method is safer and more feasible, with the potential to reduce postoperative complications, improve outcomes, facilitate better patient recovery, and thereby provide better guidance for clinical practice.

Conditions
Pancreatectomy
Being tested
stapler combined with electrocautery, simple closure with a closure device

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • stapler combined with electrocauteryProcedure or surgery

    Closure with a closure device combined with electrocoagulation for pancreatic stump closure in distal pancreatectomy

  • simple closure with a closure deviceProcedure or surgery

    Simple closure with a closure device for pancreatic stump closure in distal pancreatectomy

Study groups in NCT06424431
Study groupRoleWhat they receive
StaplerOtherSimple closure with a closure device for closure of the pancreatic remnant in distal pancreatectomy.
Receives: Procedure: simple closure with a closure device
Stapler combined with electrocauteryExperimentalClosure with a closure device combined with electrocoagulation for closure of the pancreatic remnant in distal pancreatectomy.
Receives: Procedure: stapler combined with electrocautery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pancreatic fistula

    Postoperative pancreatic fistula

    Measured: perioperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2024
  2. Study start1 Jan 2019
  3. Primary completion31 Jan 2023
  4. Study completion1 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
487 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06424431
Sponsor's protocol ID
CHEC2024-110
Status last verified
May 2024
First submitted
3 Apr 2024
Last updated
22 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing stapler combined with electrocautery and simple closure with a closure device in people with Pancreatectomy, run by Changhai Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pancreatic fistula (time frame: perioperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in